Vimarsana
Biggest News Aggregation in the World

Page 9 - Multiple Sclerosis Centers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Centers Today - Breaking & Trending Today

Cureus | A Case of Multiple Sclerosis Uncovered Following Moderna SARS-CoV-2 Vaccination - Vimarsana News

Cureus | A Case of Multiple Sclerosis Uncovered Following Moderna SARS-CoV-2 Vaccination

Multiple sclerosis is a demyelinating disorder of the central nervous system characterized by lesions disseminated in time and space. The diagnostic criteria for laboratory-supported definite multiple sclerosis involve two episodes of symptoms, evidence of at least one white matter lesion on MRI, and abnormal oligoclonal bands in cerebrospinal fluid. Patients usually present in their early 20s and on average have up to one flare-up per year. While vaccines play an important role in the prevention of many diseases, they have often been purported as a potential trigger of multiple sclerosis and ...

Source: cureus.com
Thought leaders in spinal cord injury research, science, and tech join forces with clinicians at Paralyzed Veterans of America 2022 Healthcare Summit + Expo - Vimarsana News

Thought leaders in spinal cord injury research, science, and tech join forces with clinicians at Paralyzed Veterans of America 2022 Healthcare Summit + Expo

/PRNewswire/ -- Paralyzed Veterans of America today kicked off its 10th Healthcare Summit and Expo – a four-day conference comprised of attendees from over 100...

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update - Vimarsana News

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update - Vimarsana News

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

Effect of Weight Training on SDMT Scores in Patients With MS - Vimarsana News

Effect of Weight Training on SDMT Scores in Patients With MS

Weight-based training has a slight learning effect on SDMT scores among patients with multiple sclerosis, preliminary data suggests.